Leuprolide Acetate Kit
Product Images NDC 47335-936

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 47335-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leuprolide-fig-1 (Leuprolide Fig 1)

FDA Label Image

Leuprolide-fig-10 (Leuprolide Fig 10)

FDA Label Image

Leuprolide-fig-11 (Leuprolide Fig 11)

FDA Label Image

Leuprolide-fig-12 (Leuprolide Fig 12)

FDA Label Image

Leuprolide-fig-13 (Leuprolide Fig 13)

FDA Label Image

Leuprolide-fig-2 (Leuprolide Fig 2)

FDA Label Image

Leuprolide-fig-3 (Leuprolide Fig 3)

FDA Label Image

Leuprolide-fig-4 (Leuprolide Fig 4)

FDA Label Image

Leuprolide-fig-5 (Leuprolide Fig 5)

FDA Label Image

Leuprolide-fig-6 (Leuprolide Fig 6)

FDA Label Image

Leuprolide-fig-7 (Leuprolide Fig 7)

FDA Label Image

Leuprolide-fig-8 (Leuprolide Fig 8)

FDA Label Image

Leuprolide-fig-9 (Leuprolide Fig 9)

FDA Label Image

Leuprolide-innercarton (Leuprolide Innercarton)

Leuprolide-innercarton (Leuprolide Innercarton)
Leuprolide Acetate Injection is a medication given by subcutaneous injection. The medication comes in a 2.8 mL multiple-dose sterile injection vial and contains 14 mg/2.8 mL, which is equivalent to 1 mg/0.2 mL. Each 2 mL of the medication contains euprolide acetate 1 mg (freebase 0.95 mg), sodium chloride, and benzyl alcohol as a preservative. The medication also makes use of other agents such as water, sulfuric acid and hydrochloric acid. This medication is only available on prescription and should be handled with care.*
FDA Label Image

Leuprolide-label (Leuprolide Label)

Leuprolide-label (Leuprolide Label)
This is a medication called Leuprolide Acetate. The package insert contains information on dosages. It must be stored at a temperature between 20° to 25°C (68°to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) which should not be exceeded. It is a 2.8 mL multiple-dose sterile injection vial. Protect it from light, and it is for subcutaneous injection only. It must be stored in the carton until use, and should be kept out of the reach of children. It is sold by Sun Pharmaceutical Ind., Inc., Cranbury, NJ 08512 and manufactured by Sun Pharmaceutical Ind. Ltd., India. The batch number is PJLB2394A ISS. 08/2015.*
FDA Label Image

Leuprolide-outercarton (Leuprolide Outercarton)

Leuprolide-outercarton (Leuprolide Outercarton)
This is a medication called Leuprolide Acetate Injection with a strength of 14 mg/2.8 mL (1 mg/0.2 mL), intended for subcutaneous injection. It comes in a kit with enough medication for a 14-day patient administration. A prescription is required to obtain it. A dispensing instruction is included stating that the prescription label should remain with the kit during use. The manufacturer may be SUN PHARMA. The National Drug Code (NDC) for this medication is 47335-936-40.*
FDA Label Image

Leuprolide-structure (Leuprolide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.